A Study of the Safety and Efficacy of Nebivolol in Hypertensive Patients
Status and phase
Conditions
Treatments
Details and patient eligibility
About
A study to determine the safety, efficacy and superiority of nebivolol to placebo for the treatment of elevated blood pressure in patients with mild to moderate hypertension.
Full description
This study was a multi-center, multi-national, randomized, double-blind, parallel group, placebo-controlled study of nebivolol over a range of doses in patients with mild to moderate hypertension. The study consisted of 2 phases: screening/washout/single-blind placebo run-in and 2) randomization/double-blind treatment. Patients had 7 scheduled clinic visits during the study.
Sex
Ages
Volunteers
Inclusion criteria
- An average sitting diastolic blood pressure of greater then or equal to 95 mmHg and less then or equal to 109 mmHg at baseline
Exclusion criteria
- Recent myocardial infarction or stroke
- Secondary hypertension
- Contraindications to beta-blocker therapy or discontinuation of prior antihypertensive agents
- Pregnancy, nursing or women of childbearing age not using appropriate contraception
Trial design
Primary purpose
Allocation
Interventional model
Masking
Trial contacts and locations
Loading...
Data sourced from clinicaltrials.gov
Clinical trials
Research sites
Resources
Legal